Figure 2 | Scientific Reports

Figure 2

From: Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer’s disease risk

Figure 2

Atypical chemokine receptor ACKR2-V41A and ACKR2-WT have similar levels of receptor expression on the cell surface. (A) There is no significant difference in the percent of positive cell for the atypical chemokine receptors ACKR2-V41A and ACKR2-WT (n = 5; ns = not significant) at the cell surface. (B) ACKR2-V41A and ACKR2-WT have similar cell expression levels (n = 3).

Back to article page